Jan 10 (Reuters) - Astrazeneca Plc:
* ‍FASENRA RECEIVES EU APPROVAL FOR SEVERE EOSINOPHILIC ASTHMA​
* ASTRAZENECA - ‍FASENRA IS ALSO UNDER REGULATORY REVIEW IN JAPAN AND SEVERAL OTHER COUNTRIES, WITH EXPECTED REGULATORY DECISIONS IN H1 2018​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)
Our Standards: The Thomson Reuters Trust Principles.